Issue link: https://nebusinessmedia.uberflip.com/i/1496515
Central MA Life Sciences Report 15 Largest VC deals in Central Mass. since 2018 These life sciences companies in Central Massachusetts received venture capital funding from 2018 to 2023. COMPANY CITY AMOUNT SELECT INVESTORS Mevion Medical Systems Littleton $150,000,000 YuanMing Capital, Henan Maisheng Medical Technology, HOPU Investment Management Co., Everbright Sionna Therapeutics Natick $111,000,000 OrbiMed Advisors, Atlas Venture, Qatar Investment Authority, RA Capital Management, T. Rowe Price Solid Biosciences Marlborough $75,000,000 Bain Capital Life Sciences, Perceptive Advisors, RA Capital Management, Laurion Capital Management, Pura Vida Investments, Invus, CaaS Capital Management HebeCell Natick $53,000,000 Jacobio Pharmaceuticals Akoya Biosciences Marlborough $50,000,000 Telegraph Hill Partners, Innovatus Capital Partners, Merchant Banking Avenge Bio Natick $45,000,000 CAM Capital, Perceptive Advisors, Longitude Capital, Pappas Ventures, Rock Springs Capital PIC Therapeutics Natick $35,000,000 OrbiMed Advisors, Advent Life Sciences, Belinda Termeer, Lumira Ventures, Harrington Discovery Institute Naveris Natick $33,000,000 Gurnet Point Capital, TechU Ventures, BrightEdge AffyImmune Therapeutics Natick $30,000,000 ORI Capital Pillar Biosciences Natick $29,700,000 ORI Capital, HB Ventures Mercy BioAnalytics Natick $27,277,694 The Perkins Fund CardioFocus Marlborough $27,155,857 Kennedy Lewis Investment Management D2M Biotherapeutics Natick $20,000,000 Lapam Capital, Delian Capital Pillar Biosciences Natick $20,000,000 Undisclosed investors NanoDx Southborough $18,000,000 Shepherd Kaplan Krochuk eXIthera Pharmaceuticals Westborough $17,000,000 Undisclosed investors Nirogy Therapeutics Framingham $17,000,000 Sante, Sporos Bioventures Reprieve Cardiovascular Milford $15,000,000 Lightstone Ventures Aleta Biotherapeutics Natick $13,717,679 Advent Life Sciences Phio Pharmaceuticals Worcester $7,700,000 Lincoln Park Capital Fund, OPKO Health Attivare Therapeutics Natick $6,000,000 MBX Capital Alcyone Lifesciences Ayer $5,140,609 Undisclosed investors BioStage Holliston $5,100,000 Connecticut Children's Medical Center, Bin Zhao AssayQuant Technologies Marlborough $4,500,000 Undisclosed investors CardioFocus Marlborough $4,000,000 Undisclosed investors CytoSite Biopharma Sudbury $3,049,985 Undisclosed investors Cognoptix Marlborough $2,600,000 LaunchPad Venture, Sidecar Fund2, New York Angels, Nobska Point Capital, Alopexx Enterprises ThinkGenetic Sudbury $1,500,000 Cian Robinson Latham BioPharm Group Maynard $1,350,000 Undisclosed investors Embera Neuro Therapeautics Sudbury $1,270,300 Innovation Catalyst Auxilius Pharma Hudson $1,000,000 Cofounder Zone, Augebit Fiz Neurodex Natick $1,000,000 Undisclosed investors Biosurfaces Ashland $900,000 Undisclosed investors WoundForce Framingham $500,000 Undisclosed investors Xenetic Biosciences Framingham $488,835 Baxter International Ichosia Biotechnology Worcester $190,000 Jude Gomila Gatehouse Bio Natick Undisclosed SOSV, IndieBio Lykan BioScience Hopkinton Undisclosed WindRose Health Investors Olaris Framingham Undisclosed Alumni Ventures Syner G Pharma Consulting Southborough Undisclosed Riverside Partners Prothelia Milford Undisclosed OrbiMed NeuroDex Natick Undisclosed Undisclosed investors New England Peptide Gardner Undisclosed Ampersand Capital Partners vivitide Gardner Undisclosed Ampersand Capital Partners PharmoRx Therapeutics Inc. Westborough Undisclosed Undisclosed investors Sources: CBInsights and Crunchbase